Verona Pharmaceuticals' pre-market stock price surges more than 20%.

Verona Pharmaceuticals' US stocks surged more than 20% in premarket trading. Reports say that Merck has agreed to acquire Verona Pharmaceuticals at a price of $107 per ADS, with a total transaction value of approximately $10 billion.